Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,21151,30,3.20 [1.93-5.30],6.061497554189495e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,24580,31,8.81 [3.90-19.91],1.6970710215427133e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,24644,33,5.85 [3.10-11.05],5.218990146830063e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,20653,27,4.24 [2.66-6.76],1.1792630661059788e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,20357,27,1.98 [1.53-2.56],2.443334915970262e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,24639,30,2.65 [1.86-3.77],6.211280977881961e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",24580,31,14.00 [6.91-28.40],2.5206925127401084e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,21187,31,1.99 [1.66-2.39],1.9034658721032746e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,21151,30,2.79 [2.24-3.48],9.802920505875064e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,20637,31,4.06 [3.24-5.08],5.4531982460289195e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,20637,31,3.54 [2.43-5.15],4.386606796809229e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,24580,31,8.57 [3.75-19.60],3.518618703628531e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,21187,31,3.55 [2.71-4.64],2.469652686431669e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,24429,32,31.46 [8.04-123.00],7.161372775605688e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,21211,31,1.69 [1.34-2.13],8.094756147218933e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,24477,32,1.55 [1.28-1.88],8.551846461239034e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,24477,32,5.30 [3.86-7.28],7.832902354130343e-25
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,24785,31,6.97 [4.61-10.54],3.1808221581117763e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,24535,32,8.13 [5.24-12.60],7.930402504251332e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,23902,31,3.66 [2.28-5.89],8.898267494897322e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,24545,31,22.09 [12.81-38.11],8.980091244970271e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,24673,30,8.85 [6.25-12.55],1.4240968643448482e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,24737,31,4.62 [2.69-7.93],2.7957066729405642e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,24477,32,6.33 [4.48-8.93],9.191588131409528e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,20765,30,8.15 [5.59-11.90],1.455361499725191e-27
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,24721,31,17.38 [10.57-28.57],2.1175616653163448e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,24785,31,1.77 [1.38-2.26],7.275704079699053e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,24477,32,11.10 [5.52-22.32],1.4445416941112279e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,24721,31,5.94 [3.33-10.57],1.4720584742595728e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,21187,31,3.93 [2.56-6.05],4.0433375191514366e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,21243,30,3.52 [2.08-5.95],2.723625849470625e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,24330,31,5.41 [3.24-9.01],9.510974993184579e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,21034,30,2.15 [1.69-2.73],5.001888135276321e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,24721,31,1.75 [1.40-2.19],8.787679920168024e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,24580,31,2.05 [1.53-2.74],1.1964416725577151e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,20897,30,3.16 [2.31-4.33],7.986570517089918e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,24498,32,7.46 [3.86-14.44],2.3986791816235e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,24721,31,7.25 [3.69-14.23],8.773839447637464e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,20590,31,2.20 [1.68-2.88],1.159999084653694e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,21126,29,2.52 [1.87-3.40],1.1820207737899304e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,24330,31,2.80 [2.05-3.83],1.1851334998975934e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,24639,30,2.24 [1.68-3.00],4.2475718328904745e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,21211,31,5.86 [2.68-12.78],8.943345392408143e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,24367,31,6.65 [3.80-11.61],2.902933309486769e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,24672,30,4.36 [2.45-7.75],5.186391178350604e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,24289,31,9.58 [6.40-14.36],5.927561478537825e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,24477,32,2.03 [1.68-2.46],2.312774800492354e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,24367,31,2.34 [1.94-2.81],2.379069507228385e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,20653,27,2.57 [1.86-3.55],9.214370226321666e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,23612,31,5.15 [2.70-9.83],6.700039729991723e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,24721,31,24.51 [13.83-43.42],5.744413051039059e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,21243,30,2.87 [2.05-4.02],8.099264057435104e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,24476,30,3.78 [3.14-4.56],1.4057661342922778e-44
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,24498,32,7.03 [5.01-9.87],1.5969910228998654e-29
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,24678,31,5.23 [4.19-6.52],9.657862098385768e-49
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,24040,30,5.93 [4.57-7.69],4.704588902991389e-41
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,24476,30,6.21 [3.89-9.92],1.9915388863961488e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,23902,31,2.05 [1.61-2.62],6.7149371487931e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,20637,31,2.38 [1.63-3.49],8.092429514245102e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,23864,31,4.12 [2.86-5.94],2.829901122584413e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,24040,30,5.10 [3.13-8.32],6.288069872782519e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,21148,31,2.40 [1.75-3.31],7.872192893324704e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,20255,30,2.40 [1.74-3.29],6.921948655411787e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,23909,30,2.83 [1.91-4.21],2.5346006965609624e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,24357,30,7.96 [5.06-12.54],3.4188882239040803e-19
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,24476,30,5.01 [2.72-9.24],2.3309763500478255e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,21187,31,2.64 [1.99-3.50],1.5787456192024172e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",24477,32,6.08 [3.18-11.63],4.9880115703717455e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,23909,30,2.28 [1.67-3.11],2.351505587649294e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,24781,33,24.05 [14.80-39.09],1.0051830584713217e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,20673,30,5.31 [3.25-8.66],2.3502062075130683e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,24477,32,3.05 [2.27-4.11],1.5777116170303236e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,24367,31,3.87 [3.14-4.77],9.2583695124031e-37
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,24040,30,1.67 [1.35-2.07],2.3186332722500006e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,24580,31,3.58 [2.32-5.53],9.517397847764551e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,24367,31,2.61 [1.87-3.65],1.5373904243515618e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,24785,31,4.52 [2.64-7.74],3.68592882276476e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,24040,30,4.86 [2.94-8.03],6.95201908406482e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,24040,30,6.51 [3.37-12.58],2.499678983531016e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,24785,31,2.99 [2.15-4.15],6.630584137860951e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,24543,31,6.91 [4.05-11.82],1.5442238503475948e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,24320,33,4.87 [3.53-6.72],4.049967818368248e-22
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,24477,32,5.01 [3.34-7.52],6.3737012943576495e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,23874,30,1.86 [1.42-2.44],6.859993001731764e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,23862,30,2.32 [1.79-2.99],1.3745087436818554e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",20653,27,4.26 [2.77-6.57],5.2265053377964605e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",24057,32,1.84 [1.46-2.32],2.9611664261692605e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,20771,30,2.30 [1.80-2.93],1.994651743004528e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,24367,31,2.90 [2.21-3.81],1.7603106576495294e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,24457,31,7.99 [3.98-16.02],4.7889692725465166e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,24781,33,13.80 [5.89-32.31],1.4822298521470074e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,24644,33,6.29 [3.04-12.98],6.814456158805001e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,24040,30,5.13 [2.83-9.30],7.118127547885643e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,21187,31,4.69 [2.58-8.52],4.017439006804096e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,21151,30,9.43 [4.59-19.35],9.70523103525959e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,24477,32,6.62 [4.22-10.38],1.925692409730375e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,24477,32,3.46 [2.49-4.79],1.0414088000634685e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,24477,32,7.61 [3.13-18.52],7.787244301658203e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,24248,29,38.99 [21.49-70.74],1.875477491052712e-33
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,23902,31,1.89 [1.58-2.27],7.35563166011222e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,24252,31,2.14 [1.71-2.68],3.233654214581202e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",20653,27,20.36 [6.97-59.51],3.6428792860032026e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,21187,31,3.87 [2.66-5.63],1.6596596386026885e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,21211,31,1.93 [1.47-2.53],1.953672451693849e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,21126,29,2.29 [1.65-3.18],6.652054820934542e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,20615,27,3.00 [1.88-4.78],4.1420441370511886e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,24040,30,2.17 [1.80-2.62],5.969666384063258e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,23902,31,3.95 [2.76-5.66],7.7783722748743e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,20582,31,2.69 [1.94-3.73],2.981936157437038e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,21187,31,3.68 [2.22-6.10],4.683011382849509e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,24330,31,1.90 [1.60-2.26],3.0755606594368174e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",23909,30,2.13 [1.60-2.84],2.1402041915236346e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,24781,33,37.63 [14.59-97.10],6.309676582273362e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,21211,31,4.19 [2.68-6.55],3.29575271743669e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,24367,31,6.13 [3.16-11.88],7.841927014286765e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,24477,32,1.72 [1.46-2.04],2.7433911421978246e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,21151,30,12.86 [5.83-28.41],2.6170804790924317e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,24669,30,8.49 [5.80-12.45],5.115101857090906e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,24477,32,3.24 [2.27-4.61],6.898610224613006e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,24476,30,6.22 [3.12-12.39],1.995055028277226e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,20590,31,2.35 [1.67-3.32],1.122062656132799e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",24367,31,3.10 [2.34-4.10],2.1535750483352864e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,23902,31,2.05 [1.65-2.54],8.262811223680702e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,23902,31,2.34 [1.67-3.28],9.23776260274344e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,24477,32,1.95 [1.59-2.39],9.474872852024564e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,21126,29,2.08 [1.56-2.79],7.77335174438631e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,23902,31,1.90 [1.55-2.34],1.0977062455428692e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,20582,31,2.21 [1.65-2.96],1.1839879177625769e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,24476,30,8.50 [4.12-17.53],6.761265589558802e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,21093,29,2.76 [1.85-4.11],6.537152105128541e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,24660,32,4.62 [2.38-8.93],5.625431314840229e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,21211,31,3.36 [2.24-5.04],4.3020217066755516e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,20582,31,2.34 [1.91-2.86],1.192805811809594e-16
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,20765,30,2.09 [1.53-2.87],3.9893515600806535e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,21268,30,8.58 [5.48-13.42],4.75259698541524e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,24691,33,7.54 [5.34-10.64],1.1931487593260856e-30
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,24253,31,4.85 [2.79-8.43],2.1037851380320485e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,24580,31,4.17 [2.53-6.87],2.1329778031260107e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,24477,32,2.26 [1.65-3.10],4.068650424431592e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,24704,30,4.43 [3.22-6.10],7.160958273481181e-20
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,20653,27,6.48 [3.57-11.77],8.336400273371928e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,23902,31,4.76 [3.70-6.13],7.2654242107869445e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,23902,31,4.44 [2.92-6.76],3.3859303797220325e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',21187,31,2.07 [1.71-2.51],1.147121614482627e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,20582,31,1.87 [1.47-2.37],2.5577239947167865e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,24389,30,4.65 [2.82-7.67],1.814038863228689e-09
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,24367,31,2.70 [2.03-3.59],1.0531453582289787e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,24721,31,7.26 [5.11-10.34],3.173453635436368e-28
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,21151,30,2.64 [2.11-3.30],2.920227507530921e-17
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,21187,31,3.00 [2.11-4.26],8.955986158847843e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,24285,31,2.67 [2.14-3.33],1.990627743676524e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,21243,30,4.02 [3.02-5.36],1.930998291365993e-21
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,21126,29,1.76 [1.37-2.26],9.94457970369158e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,24498,32,9.10 [4.01-20.70],1.3510007381365528e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,24016,32,2.13 [1.62-2.81],8.021398436952269e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,24504,31,5.38 [3.94-7.35],3.543251998059463e-26
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,24040,30,3.77 [3.04-4.66],3.7135831123891884e-34
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,20765,30,9.25 [5.08-16.82],3.1614032388078544e-13
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,24737,31,9.68 [5.84-16.06],1.4386886420173817e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,24721,31,3.88 [2.63-5.75],1.1041987793667878e-11
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,24330,31,5.33 [4.30-6.60],5.929241895743682e-53
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,21235,30,5.26 [2.94-9.40],2.2084828244906607e-08
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,23902,31,2.36 [1.80-3.10],5.63231431765772e-10
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,20582,31,1.90 [1.47-2.46],9.15747235138954e-07
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,24476,30,8.31 [5.14-13.45],6.573844178679103e-18
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,24514,31,12.54 [6.70-23.49],2.786718379202055e-15
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,21187,31,5.60 [2.78-11.28],1.402024998009433e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,21126,29,3.96 [2.19-7.17],5.346350309380438e-06
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,20637,31,2.81 [2.11-3.75],1.7176881294800928e-12
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,24057,32,2.96 [2.24-3.90],1.6553914453750838e-14
Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,21187,31,3.12 [2.50-3.90],1.94265521489182e-23
